HealthMore in Health→
Prime Medicine Revives Shelved Gene Therapy After FDA Shift
Prime Medicine reverses course to seek FDA approval for a previously sidelined rare immune disease therapy, citing the agency's evolving stance on rare diseases.
Key Takeaways
- Prime Medicine revives previously shelved rare immune disease therapy
- FDA's evolving stance on rare disease approvals drove the reversal
DE
DT Editorial Team··4 min read·via endpoints.news